Most bought healthcare stocks in Q4 2012
See which Healthcare stocks institutional investors increased the most in Q4 2012, measured as net growth in reported share positions from Q3 2012 into Q4 2012. Notable additions at the top of this list include MERCK & CO. INC. (MRK), PFIZER INC (PFE), ABBOTT LABORATORIES (ABT). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| MRK | MERCK & CO. INC. | 257,947 | $5.39M | 0 | 1 | 0 | 0 | 1 |
| PFE | PFIZER INC | 51,800 | $1.93M | 0 | 1 | 0 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | 23,650 | -$130.80K | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q4 2012
What are the most bought Healthcare stocks in Q4 2012?
The most bought healthcare stocks in Q4 2012 are those with the largest increase in reported share counts across institutional investors compared to Q3 2012, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2012?
Among filers in this sector, net additions were largest in companies such as MERCK & CO. INC. (MRK), PFIZER INC (PFE), ABBOTT LABORATORIES (ABT), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2012).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.